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The Hepatitis B virus core promoter regulates the expression of the core protein, the precore protein, and the viral
DNA polymerase. This promoter is transactivated by HNF4, a liver-enriched transcription factor, through an HNF4
binding site located upstream of the core promoter. The transactivation activity of HNF4 on the core promoter is
antagonized by a negative regulatory element (NRE) located upstream of the HNF4 binding site. While the NRE can
effectively antagonize HNF4 to suppress the core promoter in HeLa cervical carcinoma cells, it has only a marginal
suppressing activity on the core promoter in Huh7 hepatoma cells. By performing deletion-mapping experiments, we
have found that the NRE contains at least three independent subregions named NREa, NREb, and NREg. Each of
these three subregions possesses a weak suppressing activity, but together they generate a strong synergistic
suppressing effect on the core promoter. The NREg subregion is active in both HeLa and Huh7 cells and is bound
by a protein factor slightly less than 130 kDa in molecular mass. The NREa and NREb subregions are active in HeLa
cells but not in Huh7 cells. Thus, the marginal suppressing effect of the NRE observed in Huh7 cells was mostly due
to the activity of the NREg subregion. No clear protein factor binding sites could be identified in the NREa and NREb
subregions when the HeLa nuclear extract was used for the DNaseI-footprinting analysis, indicating weak or no
protein association with these two subregions in this cell type. However, extensive protein factor binding sites could
be identified throughout the sequences of these two subregions when the Huh7 nuclear extract was used for the
analysis. These results indicate that a different set of protein factors binds to the NREa and NREb subregions in
Huh7 cells and may account for the inactivity of these two subregions in this cell type. Thus, our results indicate
that the cell type-dependent activity of the NRE is due to differential regulation of the activities of the NREa and
NREb subregions by the cell types. This regulation is most likely mediated by cell type-dependent protein factors.
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INTRODUCTION (Ou et al., 1988). The latter has been suggested to be
important for the establishment of persistent infection
Hepatitis B virus (HBV) is a small DNA virus with a
after neonatal infection (Chen et al., 1992). The X pro-
3.2-kb circular genome. Despite its small size, the HBV
moter regulates the transcription of the mRNA encod-
genome contains four overlapping open reading ing the X protein. The X protein is a transcriptional
frames which generate at least seven viral gene prod- transactivator which can activate the expression of
ucts (for a review, see Robinson, 1990). These four PolII and PolIII genes (Aufiero and Schneider, 1990;
open reading frames, which reside in the same DNA Colgrove et al., 1989). The activities of these four pro-
strand of the HBV genome, are expressed under the moters are regulated by two enhancer elements
regulation of four different promoters named the S1, named ENI and ENII (Dikstein et al., 1990; Guo et al.,
S2, C, and X promoters. The S1 promoter regulates the 1991; Su and Yee, 1992). These two enhancer elements
transcription of the mRNA encoding the large surface display liver specificity due to the requirement of liver-
antigen and the S2 promoter regulates the transcrip- enriched transcription factors for their activities (Chen
tion of the mRNAs encoding the middle and the major et al., 1994; Garcia et al., 1993; Guo et al., 1993; Trujillo
surface antigens. These surface antigens are the viral et al., 1991; Yuh and Ting, 1991).
envelope proteins. The C (core) promoter controls the Besides the enhancer elements, the expression of the
transcription of the mRNAs encoding the core protein, HBV genes are also regulated by cis-acting negative ele-
the precore protein, and the viral DNA polymerase. ments. A CCAAT element, which resides in the S2 pro-
The core protein is the major capsid protein and the moter and is essential for the S2 promoter activity, has
precore protein is the precursor of the serum e antigen been shown to suppress the S1 gene expression (Lu et
al., 1995). In addition, we and others have identified a
negative regulatory element (NRE) located upstream of1 To whom correspondence and reprint requests should be ad-
dressed. the core promoter (Gerlach and Schloemer, 1992; Guo
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et al., 1993). This NRE can antagonize the activity of of pUCAT-NRE-AS, the SmaI–EcoRV fragment, which
contains the HBV sequence, was isolated from pUCAT-HNF4 to suppress the core promoter (Guo et al., 1993).
HNF4 is a liver-enriched transcription factor (Sladek et NRE-S and reinserted back into the SmaI–EcoRV site of
the same plasmid in an inverted orientation. Thus, pU-al., 1990). It can transactivate the core promoter approxi-
mately 20-fold through an HNF4 binding site located up- CAT-NRE-AS is almost identical to pUCAT-NRE-S except
that the HBV sequence was inverted. pUCAT-NREg-MTstream of the core promoter (Fig. 1) (Guo et al., 1993).
The NRE is located further upstream of the HNF4 binding is identical to pUCAT1 except that six point mutations
were created between nucleotides 1606 and 1622 bysite (Fig. 1). The regulation by these cis-acting negative
elements may be important for temporal regulation of site-directed mutagenesis.
HBV gene expression. Several different viruses including
Cell culture and DNA transfectionpapillomavirus and Epstein–Barr virus also contain cis-
acting negative elements in their genomes (May et al.,
HeLa cervical carcinoma cells were maintained in Dul-
1994; Montalvo et al., 1991). It has been suggested that
becco’s modified essential medium (DME) containing
these negative elements may play important roles for
10% fetal bovine serum (FBS). Huh7 hepatoma cells were
temporal regulation of viral gene expression and/or for
maintained in a medium containing 1:1 ratio of DME and
the establishment of latent infection (May et al., 1994).
F12 medium with 5% FBS. The cells were transfected by
While the HBV NRE can effectively antagonize the
the CaPO4 precipitation method as previously describedHNF4 activity to suppress the core promoter in HeLa
(Chen et al., 1994). For HeLa cells, each 60-mm plate of
cells, it has only a marginal suppression effect on the
cells was transfected with 2 mg of the reporter plasmid
core promoter activity in Huh7 hepatoma cells (Guo et
and 5 mg of the HNF4-expressing plasmid, pHNF4-S (Guo
al., 1993). Thus, the activity of the NRE is cell type-depen-
et al., 1993; Sladek et al., 1990). pLEN0, the parental
dent. How the cell types regulate the activities of the
plasmid vector of pHNF4-S (Guo et al., 1993; Sladek et
NRE remains unclear. In order to understand how the
al., 1990), was used to substitute pHNF4-S for the control
cell types regulate the NRE activity and to investigate
experiments. For Huh7 cells, since it contains endoge-
the possible role of the NRE in HBV gene expression
nous HNF4, the HNF4 expression plasmid pHNF4-S was
during HBV replication, we have further characterized
not used for cotransfection. The transfection of Huh7
this NRE. Our results reveal that this NRE contains at
cells was carried out with 7 mg of the reporter plasmid
least three different cis-acting subregions which act syn-
alone. The CAT assay was performed using our previous
ergistically to suppress the core promoter activity. One
procedures (Chen et al., 1994). In most cases, 0.5 mg
of the NRE subregions is active in both HeLa and Huh7
of plasmid pTKHGH was included in each cotransfec-
cells and is apparently recognized by a ubiquitous pro-
tion experiment for monitoring transfection efficiency.
tein factor. The other two subregions are active in HeLa
pTKHGH contains the human growth hormone sequence
cells but not in Huh7 cells. These two subregions are
under the expression control of the herpesvirus thymi-
bound by Huh7-specific factors, which may be the reason
dine kinase promoter (Chen et al., 1994). Transfection
why these two subregions are inactive in this cell type.
efficiency was monitored by measuring the amount of
The inactivity of these two subregions in Huh7 cells can
human growth hormone secreted from the transfected
explain the weak activity of the NRE in this cell type.
cells using a commercial radioimmunoassay kit (Ni-
choles).
MATERIALS AND METHODS
Nuclear extracts and DNaseI-footprinting analysisDNA plasmids
The construction of pUCAT and pUCAT1 has been HeLa nuclear extracts were prepared as described
previously (Guo et al., 1991; Guo et al., 1993). For DNaseI-described before (Guo et al., 1993). pUCAT is a promot-
erless construct which contains a unique HindIII cloning footprinting analysis, the SalI–EcoRI DNA fragment of
pUCAT6 (Guo et al., 1993) containing the HBV sequencesite in front of the chloramphenicol acetyl transferase
(CAT) reporter sequence. pUCAT1 is a derivative of pU- (adw subtype) from nucleotides 1403 to 1803 was end-
labeled with [g-32P]ATP and T4 polynucleotide kinaseCAT. In this plasmid, the HBV sequence from nucleotides
1403 to 1803 was inserted into the unique HindIII cloning and used as the probe. Thirty micrograms of the crude
HeLa nuclear extract was preincubated with 2.5 mg ofsite of the pUCAT vector. The construction of pUCAT2,
pUCAT3, pUCAT3T, pUCAT4, pUCAT4T, and pUCAT7 poly(dI–dC) on ice for 10 min in a 20-ml reaction mixture
containing 12.5 mM Tris–HCl (pH 8.0), 0.5 mM MgCl2 ,was similar to that of pUCAT1 except that different HBV
sequences were inserted into the HindIII cloning site of 50 mM KCl, 0.5 mM EDTA, and 5% glycerol. After addition
of approximately 0.05 pmol DNA probe, the reaction mix-the pUCAT vector. pUCAT-NRE-S is identical to pUCAT1
except that an EcoRV site and an EcoRI site were created ture was further incubated at room temperature for 10
min. The DNaseI digestion reaction was then carried outbetween nucleotides 1627 and 1642. For the construction
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FIG. 1. Deletion analysis of the NRE of the HBV core promoter. Top, 5*-deletion analysis; bottom, 3*-deletion analysis. Construction of the DNA
plasmids and the procedures for transfection of cells are described under Materials and Methods. The reporters were cotransfected with the HNF4
expression plasmid, pLEN4-S, into HeLa cells. Forty-eight hours after transfection, the cells were lysed and the CAT activities expressed were
measured. The CAT activity of the individual plasmid was normalized against that of pUCAT1, which contains the entire NRE previously identified
(Guo et al., 1993). The results shown represent the average of at least three different transfection experiments. a, b, and g represent the three
subregions of the NRE. HNF4 indicates the HNF4 binding site and Cp indicates the core promoter.
as previously described (Guo et al., 1993). The sample lyzed on a sequencing gel as described (Guo et al., 1991,
1993).was then analyzed on a 5% sequencing gel.
Gel-shift and methylation-interference assays UV-cross-linking analysis
The 50-bp HBV DNA fragment (nucleotides 1576 to For the preparation of the DNA probe for the UV-cross-
1626) or the 28-mer double-stranded oligonucleotide linking experiment, the oligonucleotide 5*-CACGGTGG-
containing the sequence 3 * was used as a primer and annealed to the upper
strand of the 28-mer oligonucleotide mentioned above.
The filling-in reaction was then carried out at room tem-5* TCGAGCACGTTGCATGGAGACCACCGTG 3 *
perature for 1 hr with 1 unit of Klenow enzyme and 37.5
3 * CGTGCAACGTACCTCTGGTGGCACAGCT 5*
mM each of dATP and dTTP and 100 mCi each of [a-
32P]dCTP and [a-32P]dGTP (3000 Ci/mmol, ICN) (Wen
and Locker, 1994). The UV-cross-linking experiment waswas end-labeled with [g-32P]ATP and T4 polynucleotide
performed based on the procedures of Black et al. (1994)kinase and used for the gel-shift assay. Approximately
with some modifications. The DNA probe (approximately20,000 cpm of the DNA probe was incubated with 5–10
100,000 cpm) was incubated with approximately 75 mgmg nuclear extract, 2.5 mg poly(dI–dC), and 4 mg salmon
nuclear extract, 5 mg poly(dI–dC), and 10 mg salmonsperm DNA in 20 ml of the gel-shift buffer (20 mM HEPES,
sperm DNA in 20 ml of the gel-shift buffer at room temper-pH 7.9, 40 mM KCl, 2 mM MgCl2 , 1 mM DTT, 4% Ficoll,
ature for 20 min. The reaction mixture was then irradiatedand 0.1 mM EGTA) at room temperature for 20 min. The
on ice for 30 min with 254-mm UV light from a distancesample was then electrophoresed on a nondenaturing
of 4 cm and subjected to electrophoresis on a nondena-5% polyacrylamide gel. The gel running buffer contained
turing gel. After autoradiography, the gel slice containing25 mM Tris (pH 8.0), 25 mM sodium borate, and 0.25 mM
the DNA–protein complex was isolated and the sampleEDTA. For the competition experiments, the competitors
was eluted overnight in a 100-ml solution containing 300were incubated with the nuclear extract for 10 min on
mM Tris–HCl, pH 6.8, 6% sodium dodecyl sulphate (SDS),ice prior to the addition of the probe. For the methylation-
70 mM dithiothreitol (DTT), and 15% glycerol. After a briefinterference experiments, the 50-bp DNA probe was
centrifugation in a microfuge to remove the gel debris,methylated with dimethylsulfate as previous described
the supernatant containing the sample was mixed with(Guo et al., 1991, 1993) and used for the gel-shift assay.
an equal volume of the sample buffer (80 mM Tris–HCl,The shifted DNA band identified by autoradiography was
isolated from the gel, cleaved with piperidine, and ana- pH 6.8, 2% SDS, 100 mM DTT, 10% glycerol, and 0.1%
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FIG. 2. Orientation independence of the NRE activity. The reporters were cotransfected with the HNF4 expression plasmid, pLEN4-S, into HeLa
cells and the CAT activities were measured 48 hr after transfection. The CAT activities of various plasmids were normalized against the CAT activity
of pUCAT1. The results shown represent the average of at least three independent transfection experiments.
bromophenol blue). The sample was heated at 1007 for 5 sive deletion of the sequences between nucleotides 1576
and 1646, 1519 and 1576, and 1403 and 1519 led to amin and electrophoresed on a 10% PAGE gel for analysis.
successive 2- to 3-fold increase of the core promoter
activity. Thus, the results shown in Fig. 1 narrow theRESULTS
sequence of the NRE to a 170-bp region located between
Multiple cis-acting subregions in the NRE
nucleotides 1455 and 1626 and, in addition, indicate that
this NRE contains at least three different functional sub-Previous studies have mapped the NRE to a 240-bp
region in the X protein coding sequence (Guo et al., regions located between nucleotides 1455 and 1519,
1519 and 1576, and 1576 and 1626. These three different1993). To further characterize this NRE, we have per-
formed deletion-mapping experiments in HeLa cells. The subregions, which we named NREa (nt 1455–1519),
NREb (nt 1519–1576), and NREg (nt 1576–1626), individ-reporters were cotransfected with the HNF4 expression
plasmid pHNF4-S into cells. Our previous results have ually possess a weak 2- to 3-fold suppressing activity
and together generate a strong synergistic 11-fold sup-shown that, in the absence of the NRE, HNF4 could stim-
ulate the core promoter approximately 20-fold (Guo et pressing effect.
As shown in Fig. 2, no significant loss of the sup-al., 1993). However, as shown in Fig. 1, in the presence
of the complete NRE sequence (i.e., the pUCAT1 con- pressing activity of the negative element was detected
when its orientation was inverted. Thus, similar to a si-struct), this stimulation is suppressed approximately 11-
fold. The deletion of the DNA sequence between nucleo- lencer element (Baniahmad et al., 1990), this negative
element suppressed the core promoter in an orientation-tides 1403 and 1455 did not increase the core promoter
activity. However, further deletion of the sequences be- independent manner.
tween nucleotides 1455 and 1519, 1519 and 1576, and
1576 and 1646 led to a successive 2- to 3-fold increase Cell type-dependent activity of the NRE
of the core promoter activity. Similar results were ob-
tained, if the deletion was initiated from the opposite end We have previously shown that the NRE displays little
suppressing activity on the core promoter in Huh7 hepa-of the NRE sequence. As shown in Fig. 1, introduction
of point mutations in the sequence located between nu- toma cells (Guo et al., 1993). To investigate why the NRE
is inactive in Huh7 cells, the core promoter with or withoutcleotides 1626 and 1646 to create an EcoRV restriction
site an EcoRI restriction site had no significant effect on its upstream NRE was linked to the CAT reporter and
transfected into Huh7 cells. As shown in Fig. 3, the NREthe activity of the core promoter. However, the succes-
FIG. 3. Analysis of the NRE activity in Huh7 hepatoma cells. a, b, and g represent the NREa, NREb, and NREg subregions, respectively.
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suppressed the core promoter activity only approximately
threefold in Huh7 cells (pUCAT1 vs pUCAT7). This marginal
threefold suppressing activity was not significantly affected
when the NREa and NREb subregions were deleted. This
result indicates that the marginal suppressing activity of
the NRE observed in Huh7 cells was likely mostly due
to the activity of the NREg subregion. This possibility is
supported by the observation that the deletion of the NREg
subregion from the NRE sequence was sufficient to restore
most of the core promoter activity in Huh7 cells (Fig. 3).
Thus, the results shown in Fig. 3 indicate that NREa
and NREb subregions are inactive in Huh7 cells and the
marginal suppressing activity of NRE observed in this
cell type was mostly due to the activity of the NREg
subregion.
Characterization of the NREg subregion
To further characterize the NREg subregion, the DNA
sequence from nucleotides 1576 to 1626 which contains
the NREg subregion was isolated, end-labeled with 32P,
and used as the probe for the gel-shift assay. As shown
in Fig. 4, a specific shifted signal denoted by an arrow FIG. 4. The gel-shift assay of the NREg subregion. Details of the
gel-shift assay are described under Materials and Methods. Approxi-was detected when the HeLa nuclear extract was used
mately 10 mg HeLa nuclear extract was used in the binding reactionfor the binding reaction. This signal was reduced to an
for each sample except for the sample marked ‘‘Free Probe.’’ For thisalmost undetectable level by a specific competitor con-
control sample, no nuclear extract was used in the binding reaction.
taining the sequence identical to that of the probe. On the The amounts of competitors used during the binding reactions are
other hand, this signal was not affected by a nonspecific indicated above each lane. The specific competitor used was the nonla-
beled DNA probe. The nonspecific competitor used was a double-oligonucleotide competitor (Fig. 4).
stranded oligonucleotide containing the following nonspecific se-The protein factor binding site in the DNA probe was
quence:then analyzed with the methylation-interference assay.
The same DNA probe methylated with dimethyl sulfate
5* GATACTAGTTTGTTCCTAATTAGCAAGATCATTTGT 3*
was used in the gel-shift assay. The shifted band denoted
3 * ATGATCAAACAAGGATTAATCGTTCTAGTAAACAAC 5*.by an arrow in Fig. 4 was isolated and cleaved with
piperidine. The cleaved DNA sample was then analyzed
The asterisks mark the locations of two nonspecific bands which wereon a sequencing gel. As shown in Fig. 5A, a footprint
not removed by the specific competitor. These two bands were not
was detected in both DNA strands. This assay allowed detected when a different DNA probe containing a shortened NREg
us to identify the protein factor binding site in the NREg sequence was used for the gel-shift assay (see Fig. 7A). The arrow
marks the location of the specific shifted DNA band.subregion to the sequence located between nucleotides
1606 and 1622 (Fig. 5B).
To determine whether this protein factor binding site
represents the active site of the NREg subregion, we was also detected when the Huh7 nuclear extract was used
for the reaction. Note that several minor shifted protein bandshave performed a mutagenesis experiment by randomly
mutating six nucleotides in the sequence located be- were also detected when the Huh7 nuclear extract was
used for the binding reaction. These minor bands could between nucleotides 1606 and 1622 (Fig. 5B). As shown in
Fig. 6, this mutation increased the core promoter activity generated due to binding by different Huh7 protein factors
or, perhaps more likely, due to degradation of the Huh7approximately two- to threefold in both Huh7 and HeLa
cells. This result indicates that the protein factor binding protein factor. The signals of these minor shifted bands were
significantly reduced when the Huh7 nuclear extract of asite located between nucleotides 1606 and 1622 indeed
represents the active site of the NREg subregion. different preparation was used for the assay (data not
shown). The results shown in Fig. 7A indicate that the sameA double-stranded 28-mer oligonucleotide containing the
mapped NREg sequence was then synthesized and used protein factor that binds to the NREg DNA probe is likely
present in both cell types. This possibility is supported byfor the gel-shift assay. As shown in Fig. 7A, a major shifted
band was again detected when the HeLa nuclear extract the result of the UV-cross-linking experiment shown in Fig.
7B. As shown in the figure, a cross-linked protein factor withwas used for the binding reaction. A similar shifted band
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FIG. 5. (A) The methylation-interference assay. Details of the methylation-interference assay are described under Materials and Methods. G /
A, the G / A sequence ladder; Free, the free DNA probe; Bound, the shifted DNA band shown in Fig. 4. Brackets mark the locations of the footprints.
(B) The sequence of the footprints identified in (A). The sequence of the protein factor binding site is shown in boldface. Circles mark the G residues
on which methylation affects the protein binding. The point mutations introduced into the protein factor binding site are shown above the wild-type
sequence.
molecular mass of approximately 130 kDa was identified the active site of the NREg subregion shown in Fig. 5B. No
apparent footprints were detected between nucleotides 1455when either the HeLa or the Huh7 nuclear extract was used
for the binding reaction. Excluding the molecular mass of and 1576 which include the entire NREa and NREb subre-
gions. This result indicates a weak or no association ofthe DNA probe, the protein factor that bound to the NREg
subregion will likely be slightly less than 130 kDa in size. protein factors to this region. Interestingly, when the Huh7
nuclear extract was used for the DNaseI-footprinting experi-Thus, our results shown in Fig. 7 suggest that the same
NREg factor is present in both HeLa and Huh7 cells. The ment, extensive footprints were detected throughout the en-
tire NRE sequence including the NREa and the NREb subre-presence of the same NREg factor in both cell types could
explain why this subregion is active in both cell types. gions (Fig. 8). These results indicate that a different set of
protein factors binds to the NREa and NREb subregions in
Huh7 cells. The binding by Huh7-specific protein factors toBinding by cell type-specific protein factors to NREa
the NREa and NREb subregions may be the reason whyand NREb subregions
these two subregions are inactive in Huh7 cells.
We have conducted a DNaseI-footprinting experiment us-
DISCUSSIONing the HeLa nuclear extract to examine the protein factor
binding sites in the NRE. As shown in Fig. 8, the result The HBV core promoter is stimulated by the liver-en-
riched transcription factor HNF4 (Guo et al., 1993). Thisreveals a major footprint (footprint I) which overlaps most of
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(Fig. 3). This apparently is due to the inactivity of the
NREa and NREb subregions in this cell type (Fig. 3). The
NREg subregion is active in both Huh7 and HeLa cells.
This may be due to the regulation by the same or similar
NREg protein factor(s) in these two cell types (Fig. 7).
Recently, Lo and Ting (1994) reported that a sequence
located between nucleotides 1613 and 1636 could sup-
press the ENII enhancer activity of HBV. This sequence
partially overlaps and may be structurally identical to the
active site of the NREg subregion mapped by us. If these
FIG. 6. Mutation analysis of the NREg subregion. The point mutations
two elements are indeed identical, then the NREg subre-introduced into the NREg subregion increased the CAT activity ex-
pressed by the core promoter approximately two- to threefold in both
Huh7 and HeLa cells. Solid box (WT), the wild-type reporter pUCAT1;
shaded box (Mutant), the mutant reporter pUCAT-NREg-MT. Details of
these two plasmids are described under Materials and Methods.
stimulation is suppressed in HeLa cells by an upstream
NRE in an orientation-independent manner (Fig. 2). In
this report, we have demonstrated that this NRE is com-
posed of at least three different subregions named
NREa, NREb, and NREg. In HeLa cells, these three sub-
regions individually possess a weak suppressor activity
and together generate a strong synergistic effect to sup-
press the core promoter activity (Fig. 1). The silencers of
a number of genes including the chicken lysozyme gene
(Baniahmad et al., 1990), the chicken vimetin gene (Gar-
zon and Zehner, 1994), and the collagen II gene (Savag-
ner et al., 1990) also contain multiple independent func-
tional subregions. Thus, the utilization of multiple func-
tional subregions to achieve the optimal suppressing
effect may represent one major mechanism through
which the silencers exert their activities.
While the NREg subregion is recognized by a protein
factor approximately 130 kDa in size in HeLa cells (Fig.
7B), the NREa and the NREb subregions are weakly or
not associated with proteins (Fig. 8). It has been reported
that binding by protein factors is not required for the NRE
activity of the mammalian dihydrofolate reductase gene
(Pierce et al., 1992) and for the transcriptional silencer
activity of the late promoter of the human papilloma virus
type 8 (May et al., 1994). It has been suggested that the
rigid DNA structure may be sufficient to limit interactions
of the protein factors that bind adjacent to the negative FIG. 7. (A) The gel-shift assay using both the HeLa and the Huh7
regulatory regions (May et al., 1994; Pierce et al., 1992). nuclear extracts. Details of the gel-shift assay are described under
Materials and Methods. The DNA probe used is a 28-mer double-If NREa and NREb are indeed not recognized by protein
stranded oligonucleotide containing the NREg sequence mapped byfactors in HeLa cells, then they may exert their activities
the methylation-interference experiment. Lane 1, HeLa nuclear extractto suppress the core promoter through a mechanism
used for the binding reaction; lanes 2–4, Huh7 nuclear extract used
similar to that proposed for the dihydrofolate reductase for the binding reaction. Lane 2, no competitor added in the binding
gene and the late promoter of the human papilloma virus. reaction; lane 3, 30 ng of the specific competitor added in the binding
reaction; lane 4, 30 ng of the nonspecific competitor added during theIt is interesting that the NRE of the late promoter of the
binding reaction. The arrow marks the location of the shifted DNAHPV-8 also worked in an orientation-independent man-
band. (B) The UV-cross-linking analysis of the protein factor binding toner (May et al., 1994) which resembles that of the NRE
the NREg subregion. Details of the UV-cross-linking experiment are
of the HBV core promoter (Fig. 2). described under Materials and Methods. Lane 1, HeLa protein factor
The NRE has only a marginal threefold suppressing cross-linked to the NREg DNA; lane 2, Huh7 protein factor cross-linked
to the NREg DNA.activity on the core promoter in Huh7 hepatoma cells
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protein factor binding. However, this transcriptional si-
lencer is inactivated when it is bound by the human
papilloma virus E2 protein (May et al., 1994).
In summary, our results indicate that the cell type-
dependent activity of the NRE of the HBV core promoter
is due to differential regulation of the activities of the
NREa and NREb subregions by different cell types. This
regulation involves cell type-specific protein factors. It is
possible that the activities of these two subregions are
also differentially regulated during different stages of the
replication cycle of HBV. This differential regulation will
enable HBV to activate and suppress the expression of
its core gene and may be very important for the replica-
tion of HBV.
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